Revolution Medicines, Inc. (NASDAQ:RVMDW) Short Interest Update

Revolution Medicines, Inc. (NASDAQ:RVMDW) was the target of a significant decrease in short interest in the month of December. As of December 15th, there was short interest totaling 1,373 shares, a decrease of 29.3% from the November 30th total of 1,943 shares. Based on an average daily volume of 28,634 shares, the short-interest ratio is presently 0.0 days. Based on an average daily volume of 28,634 shares, the short-interest ratio is presently 0.0 days.

Revolution Medicines Stock Down 3.3%

Shares of NASDAQ RVMDW traded down $0.03 during trading on Tuesday, reaching $0.89. 9,159 shares of the stock traded hands, compared to its average volume of 30,247. The company has a 50-day moving average of $0.63 and a 200-day moving average of $0.39. Revolution Medicines has a 52-week low of $0.03 and a 52-week high of $1.08.

Revolution Medicines Company Profile

Revolution Medicines (NASDAQ:RVMDW) is a clinical-stage oncology company focused on discovering and developing small-molecule therapies that target the RAS signaling pathway. The company’s scientific approach centers on designing molecules that selectively inhibit mutant RAS proteins and key regulators of RAS-driven cancers, with the goal of addressing tumor types that have historically been resistant to targeted therapies.

Revolution Medicines has advanced multiple pipeline candidates into clinical trials, including RMC-4630, a selective SHP2 inhibitor, and RMC-6236, an oral pan-RAS inhibitor designed to block signaling from multiple RAS mutants.